GNMSF - Genmab's (GNMSF) CEO Jan van de Winkel on Q4 2017 Results - Earnings Call Transcript
Genmab A/S (GNMSF)
Q4 2017 Results Earnings Conference Call
February 21, 2018 12:00 a.m. ET
Executives
Jan van de Winkel - President and Chief Executive Officer
David Eatwell - Chief Financial Officer
Analysts
Thomas Bowers - Danske Bank
Sachin Jain - Bank of America
Michael Novak - Nordea
James Quigley - JP Morgan
Keyur Parekh - Goldman Sachs
Carsten Madsen - SEB
Peter Welford - Jefferies
Wimal Kapadia - Bernstein
Jacob Lademann - Carnegie
Anastasia Karpova - Kempen
Presentation
Operator
Good day, everyone and welcome to the Genmab Q4 Report 2017 Conference Call. Today's conference